Theresa Staufer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Theresa Staufer has a total of 129 co-authors. Here are the top co-authors by number of shared publications:
- Florian Gruner
Universität Hamburg
15 shared publications - Christian Körnig
Universität Hamburg and Center for Free-Electron Laser Science (CFEL), Institute for Experimental Physics, Faculty for Mathematics, Informatics and Natural Sciences, Luruper Chaussee 149, 22761 Hamburg, Germany
5 shared publications - Kai Rothkamm
Laboratory of Radiobiology and Experimental Radiooncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
4 shared publications - Oliver Schmutzler
Fachbereich Physik, Universitö at Hamburg and Center for Free-Electron Laser Science (CFEL), Luruper Chaussee 149, 22761 Hamburg, Germany
4 shared publications - Neus Feliu
Fraunhofer Center for Applied Nanotechnology (CAN) Fraunhofer IAP, Grindelallee 117 20146 Hamburg Germany
3 shared publications - Wolfgang J. Parak
Universität Hamburg
3 shared publications
Latest Publications
- Open Access
- 25 October 2026
- Published by MDPI AG in Journal of Imaging
- Vol. 12 (11) , 530
Source- and Geometry-Dependent Spatial Profiles in Commercial Bioluminescence Imaging: Experimental Comparison and Geant4 Simulations
In this study, we investigated the transfer of a previously established LED-based Geant4 optical-photon simulation framework to experimental bioluminescence imaging (BLI) using two commercial imaging systems. An IVIS 200 and a SmART+ BLI/CT system were used to compare spatial intensity profiles obtained from a controlled LED source and ATP-driven bioluminescence under defined phantom conditions. Direct comparison demonstrated broader spatial profiles for BLI than for LED emission, with the magnitude of the differences varying between imaging systems. To investigate the transferability of the simulation framework, a spatially extended, isotropically emitting BLI source was implemented in Geant4, including its aqueous volume and sample container. At a phantom thickness of 2.00 mm, the simulations reproduced the general characteristics of the normalized experimental BLI profiles, although the simulated spatial profiles were consistently narrower than those measured experimentally. Separate idealized two-point-source simulations were used to investigate spatial separability under controlled phantom conditions, while additional simulations demonstrated that the source-to-boundary distance influences spatial-profile formation through changes in photon entry conditions and scattering histories. Overall, these findings demonstrate the potential of source-specific Monte Carlo simulations to investigate spatial photon transport in commercial BLI systems and to support the design and optimization of experimental studies through systematic evaluation of source and phantom parameters, potentially reducing the need for extensive experimental test series.
- 25 October 2026
- Published by MDPI AG in Journal of Imaging
- Vol. 12 (11) , 530
Open AccessSource- and Geometry-Dependent Spatial Profiles in Commercial Bioluminescence Imaging: Experimental Comparison and Geant4 Simulations
In this study, we investigated the transfer of a previously established LED-based Geant4 optical-photon simulation framework to experimental bioluminescence imaging (BLI) using two commercial imaging systems. An IVIS 200 and a SmART+ BLI/CT system were used to compare spatial intensity profiles obtained from a controlled LED source and ATP-driven bioluminescence under defined phantom conditions. Direct comparison demonstrated broader spatial profiles for BLI than for LED emission, with the magnitude of the differences varying between imaging systems. To investigate the transferability of the simulation framework, a spatially extended, isotropically emitting BLI source was implemented in Geant4, including its aqueous volume and sample container. At a phantom thickness of 2.00 mm, the simulations reproduced the general characteristics of the normalized experimental BLI profiles, although the simulated spatial profiles were consistently narrower than those measured experimentally. Separate idealized two-point-source simulations were used to investigate spatial separability under controlled phantom conditions, while additional simulations demonstrated that the source-to-boundary distance influences spatial-profile formation through changes in photon entry conditions and scattering histories. Overall, these findings demonstrate the potential of source-specific Monte Carlo simulations to investigate spatial photon transport in commercial BLI systems and to support the design and optimization of experimental studies through systematic evaluation of source and phantom parameters, potentially reducing the need for extensive experimental test series.
- Open Access
CT-Based Attenuation Correction Algorithm for Quantitative L-Shell X-Ray Fluorescence Imaging of Gold Nanoparticles in Murine Tumor Tissues
Background: Gold nanoparticles (GNPs) are widely used in nanomedicine as drug carriers, including in targeted radionuclide therapy where therapeutic radionuclides are bound to GNPs. Quantitative assessment of their biodistribution is essential. X-ray fluorescence imaging (XFI) is well suited for detecting high-Z elements, but its quantitative accuracy is compromised by strong attenuation effects, particularly in L-shell XFI where low-energy fluorescence (~10 to 12 keV) is heavily absorbed in tissue. Methods: We developed a computed tomography (CT)-guided attenuation correction algorithm for L-shell XFI. The method generates energy-dependent attenuation maps from co-registered CT data and performs voxel-wise corrections along both excitation and emission paths. The approach was tested on an ex vivo murine tumor sample resected three hours after intratumoral injection of 34.7 μg PEG-modified GNPs. Results: Application of the CT-guided correction substantially improved the relative accuracy of L-shell XFI reconstructions compared to uncorrected data. The corrected distribution maps showed consistent mass recovery across different measurement geometries, demonstrating that the algorithm compensates for the theoretically expected attenuation due to heterogeneous biological tissue. Conclusions: This study provides a proof-of-principle that CT-based attenuation correction enables more reliable and quantitative L-shell XFI of GNPs in biological samples. The approach represents a promising step toward accurate nanoparticle biodistribution assessment in biomedical research, including preclinical studies in targeted radionuclide therapy.
Open AccessCT-Based Attenuation Correction Algorithm for Quantitative L-Shell X-Ray Fluorescence Imaging of Gold Nanoparticles in Murine Tumor Tissues
Background: Gold nanoparticles (GNPs) are widely used in nanomedicine as drug carriers, including in targeted radionuclide therapy where therapeutic radionuclides are bound to GNPs. Quantitative assessment of their biodistribution is essential. X-ray fluorescence imaging (XFI) is well suited for detecting high-Z elements, but its quantitative accuracy is compromised by strong attenuation effects, particularly in L-shell XFI where low-energy fluorescence (~10 to 12 keV) is heavily absorbed in tissue. Methods: We developed a computed tomography (CT)-guided attenuation correction algorithm for L-shell XFI. The method generates energy-dependent attenuation maps from co-registered CT data and performs voxel-wise corrections along both excitation and emission paths. The approach was tested on an ex vivo murine tumor sample resected three hours after intratumoral injection of 34.7 μg PEG-modified GNPs. Results: Application of the CT-guided correction substantially improved the relative accuracy of L-shell XFI reconstructions compared to uncorrected data. The corrected distribution maps showed consistent mass recovery across different measurement geometries, demonstrating that the algorithm compensates for the theoretically expected attenuation due to heterogeneous biological tissue. Conclusions: This study provides a proof-of-principle that CT-based attenuation correction enables more reliable and quantitative L-shell XFI of GNPs in biological samples. The approach represents a promising step toward accurate nanoparticle biodistribution assessment in biomedical research, including preclinical studies in targeted radionuclide therapy.
- Open Access
- 19 August 2025
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1-13
Biodistribution of nanoplastics in mice: advancing analytical techniques using metal-doped plastics
Contamination of plastic particles in environmental and biological systems raises concerns regarding their potential negative impacts. Human exposure to microplastics (MPs) and nanoplastics (NPs) is increasing; however, some potential adverse health effects might remain unclear, due to analytical challenges in detecting trace concentrations. To address this, we propose a workflow for NPs assessment in biological samples combining three complimentary methods, namely inductively coupled plasma mass spectrometry (ICP-MS), X-ray fluorescence imaging (XFI), and imaging mass cytometry (IMC) to detect palladium-doped NPs (Pd-NPs). This approach was used to quantify the temporal distribution and accumulation of Pd-NPs in mouse models under different experimental conditions, dosages, and time frames. Acute exposure showed a clear particle excretion from the gastrointestinal tract into feces, while subchronic exposure led to tissue accumulation. This workflow enhances our ability to analyze and study NP uptake and biodistribution mechanisms down to the nanoscale in complex biological samples.
- 19 August 2025
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1-13
Open AccessBiodistribution of nanoplastics in mice: advancing analytical techniques using metal-doped plastics
Contamination of plastic particles in environmental and biological systems raises concerns regarding their potential negative impacts. Human exposure to microplastics (MPs) and nanoplastics (NPs) is increasing; however, some potential adverse health effects might remain unclear, due to analytical challenges in detecting trace concentrations. To address this, we propose a workflow for NPs assessment in biological samples combining three complimentary methods, namely inductively coupled plasma mass spectrometry (ICP-MS), X-ray fluorescence imaging (XFI), and imaging mass cytometry (IMC) to detect palladium-doped NPs (Pd-NPs). This approach was used to quantify the temporal distribution and accumulation of Pd-NPs in mouse models under different experimental conditions, dosages, and time frames. Acute exposure showed a clear particle excretion from the gastrointestinal tract into feces, while subchronic exposure led to tissue accumulation. This workflow enhances our ability to analyze and study NP uptake and biodistribution mechanisms down to the nanoscale in complex biological samples.
- Open Access
Characterization of kHz Repetition Rate Laser-Driven Electron Beams by an Inhomogeneous Field Dipole Magnet Spectrometer
We demonstrate a method to characterize the beam energy, transverse profile, charge, and dose of a pulsed electron beam generated by a 1 kHz TW laser-plasma accelerator. The method is based on imaging with a scintillating screen in an inhomogeneous, orthogonal magnetic field produced by a wide-gap magnetic dipole. Numerical simulations were developed to reconstruct the electron beam parameters accurately. The method has been experimentally verified and calibrated using a medical LINAC. The energy measurement accuracy in the 6–20 MeV range is proven to be better than 10%. The radiation dose has been calibrated by a water-equivalent phantom, RW3, showing a linear response of the method within 2% in the 0.05–0.5 mGy/pulse range.
Open AccessCharacterization of kHz Repetition Rate Laser-Driven Electron Beams by an Inhomogeneous Field Dipole Magnet Spectrometer
We demonstrate a method to characterize the beam energy, transverse profile, charge, and dose of a pulsed electron beam generated by a 1 kHz TW laser-plasma accelerator. The method is based on imaging with a scintillating screen in an inhomogeneous, orthogonal magnetic field produced by a wide-gap magnetic dipole. Numerical simulations were developed to reconstruct the electron beam parameters accurately. The method has been experimentally verified and calibrated using a medical LINAC. The energy measurement accuracy in the 6–20 MeV range is proven to be better than 10%. The radiation dose has been calibrated by a water-equivalent phantom, RW3, showing a linear response of the method within 2% in the 0.05–0.5 mGy/pulse range.
- Open Access
- 5 November 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (22) , 11880
Iodinated PSMA Ligands as XFI Tracers for Targeted Cell Imaging and Characterization of Nanoparticles
Prostate cancer is the second most commonly diagnosed cancer in men worldwide. Despite this, current diagnostic tools are still not satisfactory, lacking sensitivity for early-stage or single-cell diagnosis. This study describes the development of small-molecule tracers for the well-known tumor marker prostate-specific membrane antigen (PSMA). These tracers contain a urea motif for PSMA-targeting and iodinated aromatic moieties to allow detection via X-ray fluorescence imaging (XFI). Tracers with a triiodobenzoyl moiety allowed the specific targeting and successful imaging of PSMA+ cell lines with XFI. The XFI-measured uptake of 7.88 × 10−18 mol iodine (I) per cell is consistent with the uptake of known PSMA tracers measured by other techniques such as inductively coupled plasma mass spectrometry (ICP-MS). This is the first successful application of XFI to tumor cell targeting with a small-molecule tracer. In addition, iodinated tracers were used for the characterization of quantum dots (QDs) conjugated to PSMA-targeting urea motifs. The resulting targeted QD conjugates were shown to selectively bind PSMA+ cell lines via confocal microscopy. The immobilized iodinated targeting vectors allowed the determination of the tracer/QD ratio via XFI and ICP-MS. This ratio is a key property of targeted particles and difficult to measure by other techniques.
- 5 November 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (22) , 11880
Open AccessIodinated PSMA Ligands as XFI Tracers for Targeted Cell Imaging and Characterization of Nanoparticles
Prostate cancer is the second most commonly diagnosed cancer in men worldwide. Despite this, current diagnostic tools are still not satisfactory, lacking sensitivity for early-stage or single-cell diagnosis. This study describes the development of small-molecule tracers for the well-known tumor marker prostate-specific membrane antigen (PSMA). These tracers contain a urea motif for PSMA-targeting and iodinated aromatic moieties to allow detection via X-ray fluorescence imaging (XFI). Tracers with a triiodobenzoyl moiety allowed the specific targeting and successful imaging of PSMA+ cell lines with XFI. The XFI-measured uptake of 7.88 × 10−18 mol iodine (I) per cell is consistent with the uptake of known PSMA tracers measured by other techniques such as inductively coupled plasma mass spectrometry (ICP-MS). This is the first successful application of XFI to tumor cell targeting with a small-molecule tracer. In addition, iodinated tracers were used for the characterization of quantum dots (QDs) conjugated to PSMA-targeting urea motifs. The resulting targeted QD conjugates were shown to selectively bind PSMA+ cell lines via confocal microscopy. The immobilized iodinated targeting vectors allowed the determination of the tracer/QD ratio via XFI and ICP-MS. This ratio is a key property of targeted particles and difficult to measure by other techniques.
- Open Access
- 5 July 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (7) , 1500
Numerical Study towards In Vivo Tracking of Micro-/Nanoplastic Based on X-ray Fluorescence Imaging
There is a rising awareness of the toxicity of micro- and nanoplastics (MNPs); however, fundamental precise information on MNP-biodistribution in organisms is currently not available. X-ray fluorescence imaging (XFI) is introduced as a promising imaging modality to elucidate the effective MNP bioavailability and is expected to enable exact measurements on the uptake over the physical barriers of the organism and bioaccumulation in different organs. This is possible because of the ability of XFI to perform quantitative studies with a high spatial resolution and the possibility to conduct longitudinal studies. The focus of this work is a numerical study on the detection limits for a selected XFI-marker, here, palladium, to facilitate the design of future preclinical in vivo studies. Based on Monte Carlo simulations using a 3D voxel mouse model, the palladium detection thresholds in different organs under in vivo conditions in a mouse are estimated. The minimal Pd-mass in the scanning position at a reasonable significance level is determined to be 2 for abdominal organs and 2 for the brain. MNPs labelled with Pd and homogeneously distributed in the organ would be detectable down to a concentration of <1 μg/mL to <2.5 mg/mL in vivo. Long-term studies with a chronic MNP exposure in low concentrations are therefore possible such that XFI measurements could, in the future, contribute to MNP health risk assessment in small animals and humans.
- 5 July 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (7) , 1500
Open AccessNumerical Study towards In Vivo Tracking of Micro-/Nanoplastic Based on X-ray Fluorescence Imaging
There is a rising awareness of the toxicity of micro- and nanoplastics (MNPs); however, fundamental precise information on MNP-biodistribution in organisms is currently not available. X-ray fluorescence imaging (XFI) is introduced as a promising imaging modality to elucidate the effective MNP bioavailability and is expected to enable exact measurements on the uptake over the physical barriers of the organism and bioaccumulation in different organs. This is possible because of the ability of XFI to perform quantitative studies with a high spatial resolution and the possibility to conduct longitudinal studies. The focus of this work is a numerical study on the detection limits for a selected XFI-marker, here, palladium, to facilitate the design of future preclinical in vivo studies. Based on Monte Carlo simulations using a 3D voxel mouse model, the palladium detection thresholds in different organs under in vivo conditions in a mouse are estimated. The minimal Pd-mass in the scanning position at a reasonable significance level is determined to be 2 for abdominal organs and 2 for the brain. MNPs labelled with Pd and homogeneously distributed in the organ would be detectable down to a concentration of <1 μg/mL to <2.5 mg/mL in vivo. Long-term studies with a chronic MNP exposure in low concentrations are therefore possible such that XFI measurements could, in the future, contribute to MNP health risk assessment in small animals and humans.
- Open Access
- 17 July 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-12
Enabling X-ray fluorescence imaging for in vivo immune cell tracking
The infiltration of immune cells into sites of inflammation is one key feature of immune mediated inflammatory diseases. A detailed assessment of the in vivo dynamics of relevant cell subtypes could booster the understanding of this disease and the development of novel therapies. We show in detail how advanced X-ray fluorescence imaging enables such quantitative in vivo cell tracking, offering solutions that could pave the way beyond what other imaging modalities provide today. The key for this achievement is a detailed study of the spectral background contribution from multiple Compton scattering in a mouse-scaled object when this is scanned with a monochromatic pencil X-ray beam from a synchrotron. Under optimal conditions, the detection sensitivity is sufficient for detecting local accumulations of the labelled immune cells, hence providing experimental demonstration of in vivo immune cell tracking in mice.
- 17 July 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-12
Open AccessEnabling X-ray fluorescence imaging for in vivo immune cell tracking
The infiltration of immune cells into sites of inflammation is one key feature of immune mediated inflammatory diseases. A detailed assessment of the in vivo dynamics of relevant cell subtypes could booster the understanding of this disease and the development of novel therapies. We show in detail how advanced X-ray fluorescence imaging enables such quantitative in vivo cell tracking, offering solutions that could pave the way beyond what other imaging modalities provide today. The key for this achievement is a detailed study of the spectral background contribution from multiple Compton scattering in a mouse-scaled object when this is scanned with a monochromatic pencil X-ray beam from a synchrotron. Under optimal conditions, the detection sensitivity is sufficient for detecting local accumulations of the labelled immune cells, hence providing experimental demonstration of in vivo immune cell tracking in mice.
- Open Access
Quantitative Assessment on Optical Properties as a Basis for Bioluminescence Imaging: An Experimental and Numerical Approach to the Transport of Optical Photons in Phantom Materials
Bioluminescence imaging (BLI) is a widely used technique in preclinical scientific research, particularly in the development of mRNA-based medications and non-invasive tumor diagnostics. It has become an essential tool in current science. However, the current state of bioluminescence imaging is primarily qualitative, making it challenging to obtain quantitative measurements and to draw accurate conclusions. This fact is caused by the unique properties of optical photons and tissue interactions. In this paper, we propose an experimental setup and Geant4-simulations to gain a better understanding of the optical properties and processes involved in bioluminescence imaging. Our goal is to advance the field towards more quantitative measurements. We will discuss the details of our experimental setup, the data we collected, the outcomes of the Geant4-simulations, and additional information on the underlying physical processes.
Open AccessQuantitative Assessment on Optical Properties as a Basis for Bioluminescence Imaging: An Experimental and Numerical Approach to the Transport of Optical Photons in Phantom Materials
Bioluminescence imaging (BLI) is a widely used technique in preclinical scientific research, particularly in the development of mRNA-based medications and non-invasive tumor diagnostics. It has become an essential tool in current science. However, the current state of bioluminescence imaging is primarily qualitative, making it challenging to obtain quantitative measurements and to draw accurate conclusions. This fact is caused by the unique properties of optical photons and tissue interactions. In this paper, we propose an experimental setup and Geant4-simulations to gain a better understanding of the optical properties and processes involved in bioluminescence imaging. Our goal is to advance the field towards more quantitative measurements. We will discuss the details of our experimental setup, the data we collected, the outcomes of the Geant4-simulations, and additional information on the underlying physical processes.
- Open Access
- 1 July 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (13) , 10990
Review of Development and Recent Advances in Biomedical X-ray Fluorescence Imaging
The use of X-rays for non-invasive imaging has a long history, which has resulted in several well-established methods in preclinical as well as clinical applications, such as tomographic imaging or computed tomography. While projection radiography provides anatomical information, X-ray fluorescence analysis allows quantitative mapping of different elements in samples of interest. Typical applications so far comprise the identification and quantification of different elements and are mostly located in material sciences, archeology and environmental sciences, whereas the use of the technique in life sciences has been strongly limited by intrinsic spectral background issues arising in larger objects, so far. This background arises from multiple Compton-scattering events in the objects of interest and strongly limits the achievable minimum detectable marker concentrations. Here, we review the history and report on the recent promising developments of X-ray fluorescence imaging (XFI) in preclinical applications, and provide an outlook on the clinical translation of the technique, which can be realized by reducing the above-mentioned intrinsic background with dedicated algorithms and by novel X-ray sources.
- 1 July 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (13) , 10990
Open AccessReview of Development and Recent Advances in Biomedical X-ray Fluorescence Imaging
The use of X-rays for non-invasive imaging has a long history, which has resulted in several well-established methods in preclinical as well as clinical applications, such as tomographic imaging or computed tomography. While projection radiography provides anatomical information, X-ray fluorescence analysis allows quantitative mapping of different elements in samples of interest. Typical applications so far comprise the identification and quantification of different elements and are mostly located in material sciences, archeology and environmental sciences, whereas the use of the technique in life sciences has been strongly limited by intrinsic spectral background issues arising in larger objects, so far. This background arises from multiple Compton-scattering events in the objects of interest and strongly limits the achievable minimum detectable marker concentrations. Here, we review the history and report on the recent promising developments of X-ray fluorescence imaging (XFI) in preclinical applications, and provide an outlook on the clinical translation of the technique, which can be realized by reducing the above-mentioned intrinsic background with dedicated algorithms and by novel X-ray sources.
- Open Access
- 6 December 2022
- Published by American Physical Society (APS) in Physical Review Letters
- Vol. 129 (24) , 244801
In Situ Measurement of Electron Energy Evolution in a Laser-Plasma Accelerator
We report on a novel, noninvasive method applying Thomson scattering to measure the evolution of the electron beam energy inside a laser-plasma accelerator with high spatial resolution. The determination of the local electron energy enabled the in-situ detection of the acting acceleration fields without altering the final beam state. In this Letter we demonstrate that the accelerating fields evolve from to in a plasma density ramp. The presented data show excellent agreement with particle-in-cell simulations. This method provides new possibilities for detecting the dynamics of plasma-based accelerators and their optimization.- 6 December 2022
- Published by American Physical Society (APS) in Physical Review Letters
- Vol. 129 (24) , 244801
Open AccessIn Situ Measurement of Electron Energy Evolution in a Laser-Plasma Accelerator
We report on a novel, noninvasive method applying Thomson scattering to measure the evolution of the electron beam energy inside a laser-plasma accelerator with high spatial resolution. The determination of the local electron energy enabled the in-situ detection of the acting acceleration fields without altering the final beam state. In this Letter we demonstrate that the accelerating fields evolve from to in a plasma density ramp. The presented data show excellent agreement with particle-in-cell simulations. This method provides new possibilities for detecting the dynamics of plasma-based accelerators and their optimization.